IBL, Trans Genic to Create Joint Venture for Diagnostic Agent Development and Clinical Tests

June 21, 2012
Immuno-Biological Laboratories Co., Ltd. (IBL; Fujioka City, Gunma Prefecture) and Trans Genic Inc. (Kumamoto City, Kumamoto Prefecture) announced on June 20 that the two companies have reached a basic agreement to form a joint venture, by sharing the investment on...read more